Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 59 pseudogene (RNU7-59P) is a noncoding RNA pseudogene, analogous in sequence to functional U7 small nuclear RNA but lacking the ability to produce a functional RNA component of the U7 small nuclear ribonucleoprotein complex[1]. Functional U7 snRNA is required for the 3' end processing of replication-dependent histone pre-mRNAs and thus participates in cell cycle regulation and mRNA maturation[2][3][5][6]. However, as a pseudogene, RNU7-59P is not translated into protein and does not appear to produce a functional RNA; it is considered genomically inactive, with no known biological function or disease association. Pseudogenes are typically remnants of once-functional genes that have lost their capacity to code for proteins or perform their original function due to mutations or deletions[1]. If you are seeking a therapeutic target, the functional analog is "U7 small nuclear RNA" (U7 snRNA), not "RNA, U7 small nuclear 59 pseudogene".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 59 pseudogene (RNU7-59P).